Abstract:Objective To investigate the role of a combination of per- and post-conditioning of dexmedetomidine (Dex) in rabbits with spinal cord ischemia-reperfusion injury (SCIRI). Methods Adult New Zealand white rabbits were used to replicate the SCIRI model. Experiment 1: Animals (42) were randomly divided into seven groups to evaluate the time-course expression of p-JAK2 and p-STAT3 after reperfusion. Experiment 2: Animals (36) were randomly divided into three groups: Sham, I/R and Dex+I/R. For the I/R group and I/R+DEX group, the abdominal aorta of the rabbits was clamped for 30 min to establish the model of SCIRI, while the rabbits in the Sham group only undergoing arterial dissociation. Dex (10?μg/(kg·h) was administered intravenously 30 min before ischemia until 1?h after reperfusion. Hind limb motor function was assessed using the modified Tarlov scale score at 48?h after reperfusion. Histopathological changes and neuronal apoptosis in the ventral grey matter were assessed by hematoxylin-eosin (HE) staining and TdT-mediated dUTP nick end labeling (TUNEL). The permeability of the blood-spinal cord barrier (BSCB) was examined via Evans blue (EB) extravasation. The protein expressions of p-JAK2, p-STAT3, Cleaved Caspase-3, TNF-α, and IL-6 were detected by Western blotting. Results Experiment 1: Compared with the 0?h group, the expression of p-JAK2 and p-STAT3 in the spinal cord tissue were increased at 6?h, 12?h, 24?h, and 36?h after reperfusion (all P?0.05), and reached a peak at 24?h. Experiment 2: At 48?h after reperfusion, Dex treatment significantly increased Tarlov score (P?0.05) and alleviated the histological damage of spinal cord in rabbits; Dex treatment markedly reduced neuronal apoptosis (P?0.05) and decreased EB content in spinal cord tissue (P?0.05); Dex significantly up-regulated the expression of p-JAK2 and p-STAT3 (both P?0.05), and down-regulated the expression of Cleaved Caspase-3, TNF-α, and IL-6 (all P?0.05). Conclusions In the reperfusion phase, JAK2 / STAT3 protective pathway is activated, but it is not maintained. Combination of per- and postconditioning of Dex provided neuroprotection against spinal cord ischemia-reperfusion injury through inhibiting neuronal apoptosis and maintaining BSCB integrity, which may be related to its activation of the JAK2/STAT3 signaling pathway and the suppression of Cleaved Caspase-3, TNF-α, and IL-6.